Caleres, Inc. (CAL) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

61OpportunityDD: Oct 14, 2026Analyst: 65

paidPrice at analysis date

USD 12.3 (14/10/2026)

domainMkt cap

$424.35M

pie_chartShares

34.5M

candlestick_chart52W

trending_downShort interest

12%

INFONYSEConsumer Discretionary10500 employees

Verdict: Favorable Risk/Reward

Deep-value footwear portfolio trading at 6.4x forward P/E and ~15% FCF yield, with Famous Footwear in decline (-6% comps) offset by a Brand Portfolio compounding at +8% organic plus the newly acquired Stuart Weitzman. Guidance raised at low end for FY2026 after a 27% EPS beat in Q2. Leverage, high short interest (12%) and an open law-firm investigation keep the thesis bounded — fair value anchors around $14.50 for ~17% upside, with asymmetric optionality if Famous Footwear stabilizes.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-10-14

Caleres, Inc. (CAL)

Footwear retail & wholesale · NYSE · St. Louis

"Cheap profitable multi-brand footwear with mixed segment dynamics — value with execution risk"

Fwd P/E 6.4x FCF yield ~15% SI 12% Famous Footwear −6% comps Dividend 2.3%

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/EBITDA with P/E cross-check and SotP sanity

Fair value base case

USD 14.5

Range: USD 9.50-USD 18.0

Price at analysis date: USD 12.3 (14/10/2026)

Base upside/downside: +18%

Primary FV uses risk-adjusted consolidated EV/EBITDA (5.5x on FY2026E adj. EBITDA ~$140M). Cross-check via forward P/E vs peer median (CAL 9.2x applied vs 11.5x peer median = discount for leverage/FF decline). SotP yields a theoretical $27.47 which is intentionally not the headline FV because stand-alone BU margins are not reliably observable and consolidated-multiple is the honest frame. Sensitivity: ±1x on multiple ≈ ±$4/sh. The classification as [VALUE] is a screening criterion only; this DD derives FV independently from data. ⚠️ Not investment advice.

Component	Assumption	USD/share
Famous Footwear EV	$2.0B rev FY26E × 5% EBITDA margin = $100M × 4.0x EV/EBITDA (DBI/GCO median)	+11.59
Brand Portfolio (ex-SW) EV	$0.95B rev FY26E × 10.5% EBITDA margin = $100M × 6.5x EV/EBITDA (SHOO/WWW discount)	+18.84
Stuart Weitzman EV	$170M rev FY26E annualized × 8% EBITDA margin = $14M × 7.5x EV/EBITDA (recent acq. multiple)	+3.04
Net debt (financial)	Revolver $288M + capital leases $20M − cash $51M = $257M / 34.5M sh.	−7.45
FY26 tariff refund (after-tax, one-off)	$57.4M pre-tax × (1−24.5%) tax / 34.5M sh.	+1.26
Litigation reserve (Pomerantz tail)	10% prob × $30M expected settlement / 34.5M sh.	−0.09
Dividend expected FY26-27 (NTM)	$0.28/sh. annualized × 1.0 yr	+0.28
FV base case	Sum of lines above	≈ $27.47 gross / $14.50 risk-adjusted

Bull

$17–$20

Probability: 25%

Famous Footwear comps stabilize to flat/+1% by H2 FY27, Brand Portfolio compounds at 8-10% with Stuart Weitzman adding $160M annually at 10% EBITDA margin. Multiple re-rates to peer-median 7x EV/EBITDA. Pomerantz probe fades. Dividend hike.

Base

USD 12.3-USD 16.7

Probability: 50%

FY2026 guidance met at midpoint ($1.57 adj EPS). FF declines moderate to -3% comps. SW integrates with modest accretion. 5.5x EV/EBITDA holds. ~$14.50 FV with ~17% upside plus 2.3% dividend.

Bear

$7–$10

Probability: 25%

FF comps worsen to -8/-10%, forcing store closures. SW integration disappoints (dilutive year 1). Consumer discretionary macro turns. Multiple compresses to 4x. Pomerantz converts to filed class action. Dividend at risk.

Methodology: Primary FV uses risk-adjusted consolidated EV/EBITDA (5.5x on FY2026E adj. EBITDA ~$140M). Cross-check via forward P/E vs peer median (CAL 9.2x applied vs 11.5x peer median = discount for leverage/FF decline). SotP yields a theoretical $27.47 which is intentionally not the headline FV because stand-alone BU margins are not reliably observable and consolidated-multiple is the honest frame. Sensitivity: ±1x on multiple ≈ ±$4/sh. The classification as [VALUE] is a screening criterion only; this DD derives FV independently from data. ⚠️ Not investment advice. Not investment advice.

⚠️ Methodology note: CAL has two meaningful segments (Famous Footwear retail; Brand Portfolio owned brands) plus newly added Stuart Weitzman. FV is derived via blended EV/EBITDA on consolidated FY2026E EBITDA with a cross-check on forward P/E vs peer median, and SotP sanity check. Multiplier risk-adjusted downward from peer median to reflect Famous Footwear comp decline and leverage.

📊 Capital Structure · Short Interest · Buyback & Dilution

🔴 Short Interest

12.14%

4.19M shares short on ~34.5M outstanding. Days-to-cover ~5. Interpretation: elevated — the market has material skepticism on FF declines and leverage. Potential squeeze fuel if Q3 beats materially.

🟢 Share dilution (1Y)

−1.5%

From ~35M to ~34.5M shares via modest buybacks. Treasury acquisitions $3.1M in H1 FY2026 (vs $5M prior year). Not aggressive, but accretive at these multiples.

🟡 Buyback / Dividend

$3.1M / $0.28

Limited buyback as leverage prioritized. Quarterly dividend $0.07 maintained (ex-div Sep 11, 2026; yield 2.28%). Dividend coverage ~5x on adjusted EPS.

Short Interest — context

CAL — 12.14%

12.14%

High short interest (12%) for a dividend-paying, profitable retailer signals active bearish positioning. Catalyst for squeeze: a FY2026 EPS raise above $1.65 midpoint or Famous Footwear comp inflection. Insider activity (Form 4): one independent director added shares ~900% in April 2025; limited insider selling flagged in June 2026. Pomerantz Law investigation (June 2025) tied to Q1 2025 guidance suspension — status: investigation only, no class action filed as of this report.

$Financial analysis — FY2026

Revenue TTM

$2.85B

−3.0% YoY · guidance: low-mid single-digit growth FY26

Adj EPS FY26E

$1.50–$1.65

Guidance raised at low end (prev $1.40–$1.65)

Net debt

$237M

Revolver $288M − cash $51M · ~2.0x leverage

Operating CF (H1 26)

$55.8M

+34% YoY · FCF yield ~15% on market cap

Item	FY2024	FY2025	FY2026E	FY2027E	Guidance 2026
Revenue ($B)	2.86	2.76	2.88	3.00	Low-mid single-digit growth
Adj EPS ($)	4.19	2.78	1.57	1.85	$1.50–$1.65 (raised low end)
GAAP EPS ($)	4.11	1.96	2.87	1.80	$2.80–$2.95 (incl. $1.25 tariff refund)
Adj EBITDA ($M)	190	155	140	155	Implied margin ~4.9%
Dividend ($/sh)	0.28	0.28	0.28	0.30	$0.07 quarterly maintained

Note: FY2026E adj EPS reflects normalized earnings excluding $1.25/sh tariff refund (one-off). FY2026 GAAP EPS benefits from tariff recovery, SW gain and HQ sale ($0.09). TTM revenue $2.85B lags because FY2025 saw 6.8% Q1 decline; recovery in H2 2026 priced in.

Quarterly dynamics — last 5 quarters
Metric	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue ($M)	658.5	736.0	639.2	614.2	695.5
Gross margin %	43.4%	45.1%	44.2%	45.3%	54.8%
Adj EPS ($)	0.35	1.17	0.52	0.14	0.47
End-of-period cash ($M)	191.5	138.2	58.1	42.8	50.9

Q2 FY26 gross margin boost reflects $55.6M IEEPA tariff recovery (one-off). Underlying adj gross margin 46.8%, up 340 bps YoY — real improvement. Cash position compressed by Stuart Weitzman acquisition funding; revolver utilization increased.

Financial position and sustainability

Revolver utilization

$288/$645M

Debt/EBITDA (leverage)

2.54x

FCF yield on market cap

15.59%

Dividend coverage (adj EPS)

5.6x

account_tree

Business model — Multi-brand footwear portfolio with vertical retail

Dual-engine footwear operator — Famous Footwear + Owned Brand Portfolio

Caleres is a 148-year-old footwear company operating two complementary segments. Famous Footwear is a family footwear value retailer with 814 stores (down from 848 YoY) and a loyalty program with ~30M members. Brand Portfolio owns, licenses and distributes a stable of brands (Sam Edelman, Allen Edmonds, Naturalizer, Vionic, Dr. Scholl's, Franco Sarto, Vince, Ryka, LifeStride) plus the recently acquired Stuart Weitzman luxury brand. Brand Portfolio sells wholesale, DTC via branded stores (174) and digital. Direct-to-consumer is ~71% of total sales. The structure provides margin diversification: brands yield ~49% gross margins, retail ~43%.

Famous Footwear ~$2.00B FY26E (54% rev) 🔴 declining Family footwear value retail. 814 stores. Q2 comps −5.9%. GM 42.7%. Price-sensitive, back-to-school seasonal exposure, under pressure from off-price channels (TJX, BURL). Store rationalization in progress. Brand Portfolio (owned) ~$1.00B FY26E (34% rev) 🟢 compounding Sam Edelman, Naturalizer, Vionic, Dr. Scholl's, Allen Edmonds, Franco Sarto, Vince. Q2 organic +8.2% ex-SW. GM 49% adj. International +18% organic. Growth engine funds dividend and FF rationalization. Stuart Weitzman ~$170M FY26E annualized (12% rev) 🟡 integrating Luxury women's footwear acquired 2025 from Tapestry (~$105M consideration). $42.5M Q2 contribution. Integration ongoing. Expected to lift Brand Portfolio GM and add global reach, but one-time integration costs weigh FY26.

gavel

Legal, regulatory and risk analysis

Famous Footwear comp decline

High

Q2 comps −5.9%, guidance FY26 "low-mid single-digit decline". FF is 54% of revenue; sustained decline erodes consolidated EBITDA and triggers store closures. Deterioration risks peer-multiple compression.

Leverage & revolver

Moderate

Net debt $237M, revolver drawn $288M of $645M. Debt/EBITDA 2.5x — manageable but limits buyback flexibility. Rising rate environment adds ~$16M interest annually. Lease obligations ~$1B imputed add shadow leverage.

Pomerantz Law investigation

Moderate

Investigation announced June 2025 following Q1 2025 miss and guidance suspension. No class action filed as of Oct 2026. Tail risk: formal filing could create $20-50M liability and overhang. Weight ~10% probability in base.

Consumer discretionary macro

Moderate

Footwear is discretionary; macro slowdown would hit FF immediately. Back-to-school 2026 slightly below plan. Tariff policy evolving; Q2 IEEPA refund was one-off but future rulings uncertain.

Stuart Weitzman integration

Moderate

Acquired late 2025. Integration costs weigh FY26 adj EPS ($0.04 charge disclosed). Luxury footwear exposure new to CAL — distribution overlap limited. Successful execution adds optionality; miss creates write-down risk.

Deep value quality

Positive

Forward P/E 6.4x, P/B 0.64, P/S 0.15, FCF yield ~15.6%. Multiple margin-of-safety signals vs peers at 11-18x. Dividend 2.3% is additional downside support. Insider director added shares 900% in 2025.

Brand Portfolio growth engine

Positive

Owned brands grew +8% organic Q2 2026 with GM 49%. Sam Edelman, Naturalizer, Vionic are category leaders. International +18% organic signals runway. Combined with SW, Brand Portfolio could reach $1.2B+ by FY27.

Short interest & squeeze fuel

Positive

12% SI, 5 days-to-cover. A FY26 EPS beat at upper end ($1.65+) or FF stabilization headline could trigger a squeeze in a thinly-covered name. Market cap only $424M; sensitivity to catalysts is high.

article

SWOT analysis

Strengths

+148-year brand heritage, DTC 71% of mix (margin-rich)
+Multi-brand portfolio diversifies category risk
+Positive FCF, dividend-paying through cycles
+Brand Portfolio growing +8% organic with 49% GM
+Deep valuation discount (6.4x fwd P/E vs peer 11.5x)

Weaknesses

−Famous Footwear chronic comp decline (−6% Q2)
−Operating margin thin ~2% consolidated
−Leverage: revolver $288M, net debt 2.5x EBITDA
−GAAP EPS flattered by one-off tariff refund in FY26
−Buyback capacity constrained by leverage priority

Opportunities

→Stuart Weitzman integration accretion from FY27
→International Brand Portfolio +18% organic — runway
→FF rationalization could lift segment EBITDA margin
→Short squeeze on a positive catalyst (SI 12%)
→Multiple re-rating toward peer median = ~$20

Threats

!Pomerantz Law filing could escalate to class action
!Consumer discretionary slowdown hits FF immediately
!Off-price (TJX, BURL) continuing share gains
!Tariff policy reversal — Q2 refund was one-off
!Dividend cut if FF comps worsen beyond −8%

article

Summary by assessment area

Valuation

Forward P/E 6.4x, lowest in peer set
P/S 0.15, P/B 0.64 — margin of safety
FV base $14.50 vs price $12.30 (+17.9%)
FCF yield ~15.6% supports dividend + buyback

Operations

Famous Footwear −6% comps: structural headwind
Brand Portfolio +8% organic ex-SW: growing
Q2 EPS beat +27% ($0.47 vs $0.37)
FY26 adj EPS guidance raised at low end

Risks

Pomerantz investigation — tail legal risk
Short interest 12% — bearish positioning
Leverage 2.5x — limits flexibility
Consumer discretionary macro overhang

Sources & Disclaimer

Sources: Caleres Q2 2026 earnings release (Business Wire, Sep 9, 2026); Caleres 8-K SEC filing cal-20260909xex99d1; stockanalysis.com/stocks/cal (price $12.30 close Oct 13, 2026 — verified via Robinhood 2026-10-14); Yahoo Finance CAL (52W range verified); Pomerantz Law Firm investor alert (June 2025); peer data from stockanalysis.com for DBI, SHOO, WWW, GCO. Last verified close 2026-10-13. ⚠️ Not investment advice. This document is for informational purposes only and does not constitute financial or investment advice.